Centro di Referenza Nazionale (CRN) per l’Antibioticoresistenza

Istituto Zooprofilattico Sperimentale del Lazio e della Toscana M. Aleandri
Istituto Zooprofilattico Sperimentale del Lazio e della Toscana M. Aleandri
Senza categoria

Pagina di prova Gram + CB

Elenco di possibili molecole antibiotiche per la valutazione della sensibilità in agenti batterici patogeni Gram positivi isolati nel bovino.
Gram +vi$ CLSI VET 01S-Ed 6 CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Beta Lattamici Penicillina Staphylococcus spp (HD) P NP P P NP P NP NP NP P NP P NP NP P
Penicillina (Streptococcus beta haemolytic group HD) P NP NP P NP NP NP NP NP P NP P NP NP P
Penicillina (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP P
Cefoxitina^ Staphylococcus (HD) P NP P P NP P NP NP NP NP NP NP NP NP P
(Ceftiofur) NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Cefotaxime^ Staphylococcus spp (HD) NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Cefotaxime (Streptococcus beta haemolytic group ) NP NP NP P NP NP NP NP NP NP NP NP NP NP NP
Cefotaxime (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP NP
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
(Fluoro)chinolonici Ciprofloxacin Staphylococcus spp (HD) NP NP NP P p P NP NP NP NP NP NP NP NP P
Ciprofloxacin (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP P
Ciprofloxacin S.agalactie NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Enterofloxacin (Staphylococcus) NP NP NP NP NP NP NP NP NP P NP P NP NP NP
Enterofloxacin (Streptococcus ) NP NP NP NP NP NP NP NP NP P NP P NP NP NP
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Aminoglicosidi (Aminociclitoli) Kanamicina Staphylococcus spp (HD) NP NP NP NP NP NP NP NP NP P NP P NP NP P
(Kanamicina) Streptococcus spp NP NP NP NP NP NP NP NP NP P NP P NP NP NP
Gentamicina Staphylococcus spp (HD) P P P P p P NP NP NP P NP P NP NP P
Gentamicina (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP NP
(Gentamicina) Streptococcus NP NP NP NP NP NP NP NP NP P NP P NP NP NP
(Gentamicina) Streptococcus agalactiae NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Macrolidi Eritromicina (Staphylococcus HD) P P P P p P NP NP NP P NP P NP NP P
Eritromicina Streptococcus spp (HD) P P P NP NP NP NP NP NP P NP P NP NP NP
Eritromicina (Streptococcus beta haemolityc group) NP NP NP P p P NP NP NP NP NP NP NP NP P
Eritromicina (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Lincosamidi Clindamicina Streptococcus spp (HD) P P P NP NP NP NP NP NP NP NP NP NP NP NP
Clindamicina Staphylococcus spp (HD) NP NP NP P P P NP NP NP NP NP NP NP NP P
Clindamicina (Streptococcus beta haemolityc group) NP NP NP P P P NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Rifaximine Rifampicina Staphylococcus spp (HD) P P P P P P NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Amfenicoli Cloramfenicolo§ Staphylococcus spp (HD) P P P P P P NP NP NP P NP P NP NP P
Cloramfenicolo§ Streptococcus spp (HD) P P P NP NP NP NP NP NP P NP P NP NP NP
Cloramfenicolo (Streptococcus beta haemolityc group) NP NP NP P P P NP NP NP NP NP NP NP NP NP
Florfenicol (Staphylococcus spp) NP NP NP NP NP NP NP NP NP P NP P NP NP P
Florfenicol (Streptococcus beta haemolytic group) NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Sulfonamidi Sulfonamidi (Staphylococcus spp) NP NP NP NP NP NP NP NP NP P NP P NP NP NP
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Trimethoprim Trimethoprim (Staphylococcus) NP NP NP NP NP NP NP NP NP P NP P NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Tetracicline Tetraciclina Staphylococcus spp (HD) P P P P P P NP NP NP P NP P NP NP P
Tetraciclina Streptococcus spp (HD) P P P P P P NP NP NP P NP P NP NP NP
Tetraciclina (Streptococcus spp beta haemolytic group) NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2021 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Trimethoprim-sulfamethoxazole Tetraciclina Staphylococcus spp (HD) P NP P P NP P NP NP NP NP NP NP NP NP P
Streptococcus spp NP NP NP NP NP NP NP NP NP P NP P NP NP P

Note:

  • P: Clinical breakpoint/Epidemiological cutoff presente
  • NP: Clinical breakpoint/Epidemiological cutoff non presente
  • HD: Human-derived (breakpoints derivati dallo Standard Umano, come da documento CLSI VET)
  • $ Per Staphyloccus aureus, Streptococcus, altri Gram +vi (Trueperella pyogenes)
  • ^ Per Staphylococcus aureus
  • Gli antibiotici tra parentesi sono da considerarsi facoltativi

 

8 giugno 2023 Senza categoria

Skip to content